2. Scientist enabling scientists
For over 30 years, Enzo
has been providing
enabling technologies
for the research,
development,
manufacture, licensing
and marketing of
innovative health care
products, platforms and
services based on
molecular and cellular
technologies.
3. Enzo Biochem
Enzo (ENZ)
• Founded in 1976
• Company led by
Dr. Elazar Rabbani
• Ph.D in Biochemistry
• Company founder
4. Segmented to align with
our customer needs
Enzo (ENZ)
• Divided into 3 segments:
Life Sciences
Clinical Labs
Therapeutics
• 500+ employees globally
• 40,000+ product portfolio
focused on the research
market.
5. Enzo Biochem Family
Enzo Biochem
Enzo Clinical Enzo Life Enzo
Labs Sciences Therapeutics
Enzo Direct
Axxora
6. Segmented to align with
our customer needs
Enzo Biochem (ENZ) : FY2010
FY2010 Life Therapeutics Clinical Labs Other Consolidated
Sciences
Revenues* $52,904 $ - $44,178 $ - $97,082
Operating 49,742 2,502 51,727 - 119,140
Expenses*
Operating 3,162 (2,502) (7,549) (15,169) (22,058)
Income*
14%
investment
(*,000) in R&D
7. Global Reach
ELS Headquarters
Research,
Manufacturing,
Customer Service sites
Enzo Life Sciences has offices across the globe to ensure
efficient service & delivery to our customers.
8. Enzo Life Sciences –
Increasing focus in key scientific areas
- Leverage origins
Enzo established itself as a leader within
the Molecular Biology market space.
Today, we still serve that area, but also rely
on those roots to complement our efforts
within other life science spaces.
- Acquisitions in key areas
Expertise expanded with the acquisition of
several technology companies including:
- 2007: Alexis Biochemicals
- 2008: Biomol International
- 2009: Assay Designs / StressGen
- Sales Channels
- Direct ELS products
- Distribution network
- Axxora company
9. Enzo Life Sciences Market Focus
Small
Cellular Molecular Proteostasis
Molecule
Analysis Biology & Epigenetics
Chemistry
Custom Services
10. Cellular Analysis
Quality products enabling a unique array of
possibilities in cell detection & characterization
• Live Cell analysis kits
• High Content Screening
• Organelle visualization
• In Vitro Toxicology
• Cellestial Dyes include fluorescent probes that offer
broadest range of excitation & emission profiles
Cellular • Assays compatible with flow cytometry,
Analysis fluorescent microscopy and microplate formats
Live Cell Analysis – Autophagy detection by flow cytometry
Cellestial Dyes • Wide portfolio of proteins, antibodies & reagents for
Antibodies
analysis of cell processes and response
Proteins
• Apoptosis reagents
Reagents
• Inducers, inhibitors & detection solutions for
studying oxidative stress
11. Drug Development
Let our experience work for you
• Unique collection of focused Screen-Well™ compound
libraries
• Current catalog of over 3,000 stand-alone small
molecules including;
• Natural products
• Enzyme inhibitors
• Receptor ligands
• Drugs
Small • Lipids
Molecule • Fatty acids
Chemistry • Global Sourcing capabilities thought a supplier network
Screen-Well™ built on more than 25 years of experience.
Compound Libraries
Unique small molecules
12. Molecular Biology
Established products enabling high
sensitivity
• BioArray® RNA Amplification & labeling systems and
cDNA synthesis kits offer a convenient all-in-one
system for gene expression analysis
• Comparative Genomic Hybridization (CGH) analysis
products are specifically optimized and validated for
Molecular both BAC and oligonucleotide arrays
Biology • Superior DLR scores
BioArray Kits • Validated for high density arrays
CGH labeling Kits • A comprehensive portfolio of high quality modified
Fluorescent dUTPs nucleotides and nucleic acid labeling systems
providing all the necessary tools for in situ
hybridization and FISH applications
• Fluorescent dUTPs, and Nick Translation DNA
Labeling kits
13. Proteostasis
Enabling discovery across a wide network
of protein processes.
• Detection & characterization products for a
multitude of processes central to proteostasis:
• Protein synthesis, folding and unfolding
• Post-translational modification
• Protein degradation
• Most comprehensive heat shock protein portfolio
available.
Proteostasis • Only HSP70 validated for plasma & serum
& Epigenetics • Only source for HSP70B ELISA
ProteoStat™ Detection • ProteoStat™ assays for characterization,
Assays
UbiQapture Kits
formulation and process development of protein
ELISA Kits therapeutics
HDAC kits • Sensitive aggregation detection assays
• Protein A ELISAs for contamination
detection
• Drug Discovery kits
• Epigenetics
• Proteases
• Caspases
14. Valued partner in the
Life Sciences arena
- A solid infrastructure build on 30
years of business acumen.
- An established global network to
efficiently supply product and
provide timely technical support.
- Strong R&D investment to keep a
continued stream of innovative
products flowing to the market.
- 1,000s of scientific references
supporting our broad portfolio of
reliable products.
- Leading scientists regularly
collaborating with our customers to
stay connected and produce
thoughtful products.
